Literature DB >> 7012623

Chronic myelogenous leukemia--new concepts (first of two parts).

H P Koeffler, D W Golde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7012623     DOI： 10.1056/NEJM198105143042004

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  30 in total

1.  Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha.

Authors:  R Hehlmann; B Anger; D Messerer; R Zankovich; L Bergmann; H J Kolb; P Meyer; U Essers; U Queisser; H Vaupel
Journal:  Blut       Date:  1988-02

Review 2.  Chronic myelogenous leukemia of childhood.

Authors:  K L Saving
Journal:  Indian J Pediatr       Date:  1987 Nov-Dec       Impact factor: 1.967

3.  The isochromosome (17q) in chronic myelocytic leukaemia: mechanism of origin, centromeric function and clonal evolution.

Authors:  F Pasquali; C Panarello; P Bernasconi; R Casalone
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

4.  Bone marrow transplantation for chronic granulocytic leukaemia.

Authors:  H K Mahmoud; U W Schaefer; F Schüning; D Beelen; R Becher; C G Schmidt; W Alberti; E Haralambie; G Linzenmeier; B Stollmann
Journal:  Klin Wochenschr       Date:  1985-06-18

5.  Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia with interferon alpha.

Authors:  G Egert; L Kanz; G W Löhr; A A Fauser
Journal:  Blut       Date:  1990-05

6.  Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b.

Authors:  N Niederle; O Kloke; D May; R Becher; R Osieka; C G Schmidt
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

7.  P53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study.

Authors:  A Rovira; A Urbano-Ispizua; F Cervantes; M Rozman; J L Vives-Corrons; E Montserrat; C Rozman
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

8.  Neutrophil product with lymphocyte activating factor activity.

Authors:  P J Harris
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

9.  Meningeal leukaemia in the blastic phase of chronic granulocytic leukaemia.

Authors:  H Van Bever; Y Benoit; M J Delbeke; E Orye
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

10.  Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML).

Authors:  O A Haas; J D Schwarzmeier; E Nacheva; P Fischer; E Paietta
Journal:  Blut       Date:  1984-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.